Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Amazon Explores AI Content Marketplace With Media Publishers 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
MOORESTOWN, N.J., March 14, 2018 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, today announced that Chief Financial Officer, Brian Adams, will participate in Oppenheimer 28th Annual Healthcare Conference in New York City.
The TRHC Management Team’s presentation is scheduled on Wednesday, March 21, 2018 at 8:00 a.m. EDT.
About Tabula Rasa HealthCare
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, www.TRHC.com.
Contact:
Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]
Media
Dianne Semingson
[email protected]
T: 215-870-0829
